The correct administration of Dymista® will lead to optimum efficacy, thereby increasing patient compliance
The correct use of Dymista® is imperative for optimum efficacy and to minimise side effects. Patients should be shown how to use Dymista® following the simple step by step instructions or watching the how to use video
Further Your Understanding
Click on one of the below links to discover more information about Dymista®, including Flow to use Dymista®, guidelines, clinical papers and request materials.
Impact of Rhinitis
- Price D Bousquet J. Bachert C el al. MP29.o2 a novel intranasal therapy for the treatment of chronic rhinitis: safety data from a 12 month trial. Presented at EEAACI Geneva 16-21 June 2013. Patients were chronic AR patients treated over 12 months at the recommended dosages. Dymista® (n=404). FP (n=207)